PHP Biotech

[On Demand]
After the development of a molecule with proven anti-tumor action with several tests carried out, PHP Biotech was born with an exclusive focus on the development of a drug for the treatment of breast cancer of the triple-negative type.
The company was founded during the “pink October” in 2020. The result of a partnership between Kaivo Biotech, a national research and development company for innovative biological products, FCJ Venture Builder, and the addition of a team with more than 20 years of experience in the area of ​​R&D and the Pharmaceutical Industry.